PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Levocetirizine - Allergic rhinitis
PAD Profile : Levocetirizine - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, non-sedating antihistamines
Brand Names Include :
Xyzal
Traffic Light Status
Status 1 of 2.
Status :
Green (see narrative)
Important
Formulations :
- Tablets
Important Information :
Not a 1st-line option.
Use cetirizine or loratadine 1st-line.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Cetirizine hydrochloride
- Loratadine
- Desloratadine
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Desloratadine and levocetirizine are not recommended 1st line as there is little evidence that they confer any additional benefit over the more established non-sedating antihistamines and are more costly - see local guidelines below
Cetirizine or loratadine are the 1st line non-sedating antihistamines
Levocetirizine liquid is non-formulary
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines